Sale to Omnicell, Inc.

Healthcare
Technology & Services
Sale to Omnicell, Inc.

Summary

Baird served as the exclusive financial advisor to Aesynt, Inc. on this transaction.

About

Aesynt, Inc. (“Aesynt” or the “Company”), a portfolio company of Francisco Partners Management LLC (“Francisco Partners”), was recently acquired by Omnicell, Inc. (NASDAQ: OMCL) (“Omnicell”) for $275 million.

Aesynt combines healthcare expertise with a comprehensive portfolio of pharmacy automation and information management tools. The Company partners with healthcare organizations to fully optimize all medication forms enterprise-wide, driving cost reductions and improved patient safety. With leading solutions for sterile compounding, enterprise-wide inventory management and medication dispensing, Aesynt is committed to developing innovative solutions to solve the most pressing challenges for the Company’s global healthcare partners. Aesynt is headquartered in Cranberry Township, Pennsylvania.

Francisco Partners is a global private equity firm specializing in investments in technology and technology-enabled services businesses. Since its launch over 15 years ago, Francisco Partners has raised approximately $10 billion in capital and invested in more than 150 technology companies, making it one of the most active and longstanding investors in the technology industry. Francisco Partners invests in transaction values ranging from $50 million to over $2 billion, where the firm's deep sector knowledge and operational expertise can help companies to realize their full potential. Francisco Partners is based in San Francisco, California.

Omnicell is a leading supplier of comprehensive automation and business analytics software for patient-centric medication and supply management across the entire healthcare continuum – from the acute care hospital setting to post-acute skilled nursing and long-term care facilities to the home. More than 3,000 customers worldwide have utilized Omnicell Automation and Analytics solutions to increase operational efficiency, reduce errors, deliver actionable intelligence and improve patient safety. Omnicell is headquartered in Mountain View, California.

For additional information about this transaction, please contact:

Bill Suddath +1 (404) 264-2222
James Weck +1 (312) 609-4675
Brian McDonagh +1 (704) 553-6611
John Moriarty +1 (650) 858-3811
Nick Anderson +1 (312) 609-7061
Michael Wolff +49 (69) 130 149 49
Healthcare
Technology & Services
Sale to Omnicell, Inc.
Date
January 2016
Company
Aesynt, Inc.
Transaction
M&A
Sectors
Healthcare
Technology & Services
Target Location
North America
Acquiror Location
North America

Share